Navegar por autor "Echarri Piudo, Ana"

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine

2011- Echarri Piudo, Ana; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Carracedo Álvarez, Ángel; Barros Angueira, Francisco; [et al.]

Application of new technologies as educational tool for Inflammatory Bowel Disease patients

2015- Echarri Piudo, Ana; Ollero Pena, Virginia; Morete Pérez, María Carmen; Fraga Iriso, Rebeca; García Diéguez , Leticia [et al.]

Can fecal calprotectin (FC) predict activity in the MR-enterography in small bowel Crohn's disease (CD)?

2014- Echarri Piudo, Ana; Gallego Ojea, Jose Carlos

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis

2012- Echarri Piudo, Ana; Barreiro de Acosta, Manuel

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis

2011- Echarri Piudo, Ana; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Carracedo Álvarez, Ángel; Barros Angueira, Francisco; [et al.]

Clinical characteristics of inflammatory bowel disease in elderly patients

2013- Echarri Piudo, Ana; Ollero Pena, Virginia; Castro Alvariño, Javier; Castro Ortiz, Elena

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice

2015- Echarri Piudo, Ana; Ollero Pena, Virginia; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Lorenzo González, Aurelio [et al.]

Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis

2015- Echarri Piudo, Ana; Ollero Pena, Virginia; Fraga Iriso, Rebeca; García Diéguez , Leticia

Enfermedad de Crohn: utilidad de la RM-enterografia en la deteccion de recurrencias posquirurgicas

2011- Echarri Piudo, Ana; Gallego Ojea, Jose Carlos; Porta Vila, Ana

Evaluation of safety and effectiveness of adalimumab therapy in symptomatic ileal Crohn's disease strictures

2011- Echarri Piudo, Ana; Gallego Ojea, Jose Carlos; Ollero Pena, Virginia; Porta Vila, Ana; Castro Alvariño, Javier [et al.]

Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

2015- Echarri Piudo, Ana; Barreiro de Acosta, Manuel; Carracedo Álvarez, Ángel; Barros Angueira, Francisco; Zabala Fernández, William [et al.]

Experience with metronidazole topical therapy to treat dermatological lesions related to inflammatory bowel disease (IBD)

2014- Echarri Piudo, Ana; Morete Pérez, María Carmen; Fuster Sanjurjo, Lucía; Fraga Iriso, Rebeca

Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score

2015- Echarri Piudo, Ana; Gallego Ojea, Jose Carlos

Guía itinerario formativo tipo (GIFT) Aparato digestivo

2021-06- Echarri Piudo, Ana

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study

2020- Echarri Piudo, Ana; Vera, Isabel; Ollero Pena, Virginia; Arajol, Claudia; Riestra, Sabino; [et al.]

Ileal Crohn's disease: MRI with endoscopic correlation

2011- Echarri Piudo, Ana; Gallego Ojea, Jose Carlos; Ollero Pena, Virginia; Porta Vila, Ana

Impact of postinduction infliximab trough level and disease activity on primary response in Crohn's Disease

2015- Echarri Piudo, Ana; Cid Fernández, José Javier; Soto Iglesias, Santiago

Inflammatory bowel disease and complicated perianal fistulas. A 15 year follow-up

2013- Echarri Piudo, Ana; Ollero Pena, Virginia; Morete Pérez, María Carmen; Puig Millares, Purificación Elvira; Fuster Sanjurjo, Lucía; [et al.]

Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study

2015- Echarri Piudo, Ana; Castro Alvariño, Javier; Barreiro de Acosta, Manuel

Letter: double-dose intensification - a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

2019- Echarri Piudo, Ana; Molina Arriero, Gema; Sagastagoia Epelde, Olatz; Fuster Sanjurjo, Lucía; Fraga Iriso, Rebeca; [et al.]

Repositorio digital RUNA

Navegar por autor "Echarri Piudo, Ana"

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine ﻿

Application of new technologies as educational tool for Inflammatory Bowel Disease patients ﻿

Can fecal calprotectin (FC) predict activity in the MR-enterography in small bowel Crohn's disease (CD)? ﻿

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis ﻿

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis ﻿

Clinical characteristics of inflammatory bowel disease in elderly patients ﻿

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice ﻿

Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis ﻿

Enfermedad de Crohn: utilidad de la RM-enterografia en la deteccion de recurrencias posquirurgicas ﻿

Evaluation of safety and effectiveness of adalimumab therapy in symptomatic ileal Crohn's disease strictures ﻿

Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients ﻿

Experience with metronidazole topical therapy to treat dermatological lesions related to inflammatory bowel disease (IBD) ﻿

Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score ﻿

Guía itinerario formativo tipo (GIFT) Aparato digestivo ﻿

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study ﻿

Ileal Crohn's disease: MRI with endoscopic correlation ﻿

Impact of postinduction infliximab trough level and disease activity on primary response in Crohn's Disease ﻿

Inflammatory bowel disease and complicated perianal fistulas. A 15 year follow-up ﻿

Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study ﻿

Letter: double-dose intensification - a quick way to reverse antibody formation and loss of response in patients treated with adalimumab ﻿

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine

Application of new technologies as educational tool for Inflammatory Bowel Disease patients

Can fecal calprotectin (FC) predict activity in the MR-enterography in small bowel Crohn's disease (CD)?

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis

Clinical characteristics of inflammatory bowel disease in elderly patients

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice

Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis

Enfermedad de Crohn: utilidad de la RM-enterografia en la deteccion de recurrencias posquirurgicas

Evaluation of safety and effectiveness of adalimumab therapy in symptomatic ileal Crohn's disease strictures

Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

Experience with metronidazole topical therapy to treat dermatological lesions related to inflammatory bowel disease (IBD)

Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score

Guía itinerario formativo tipo (GIFT) Aparato digestivo

The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study

Ileal Crohn's disease: MRI with endoscopic correlation

Impact of postinduction infliximab trough level and disease activity on primary response in Crohn's Disease

Inflammatory bowel disease and complicated perianal fistulas. A 15 year follow-up

Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study

Letter: double-dose intensification - a quick way to reverse antibody formation and loss of response in patients treated with adalimumab